The impact of metastasectomy on survival of patients with synchronous metastatic renal cell cancer in Finland: A nationwide study.
Lauri LaruHanna RonkainenPasi OhtonenMarkku H VaaralaPublished in: Scandinavian journal of surgery : SJS : official organ for the Finnish Surgical Society and the Scandinavian Surgical Society (2024)
Complete metastasectomy, when possible, can be considered as a treatment option for selected patients with synchronous mRCC who are fit for surgery. By contrast, we found no survival benefit from an incomplete metastasectomy suggesting that such procedures should not be performed for these patients.
Keyphrases
- end stage renal disease
- chronic kidney disease
- newly diagnosed
- ejection fraction
- squamous cell carcinoma
- magnetic resonance
- peritoneal dialysis
- prognostic factors
- papillary thyroid
- free survival
- cell therapy
- coronary artery bypass
- mesenchymal stem cells
- patient reported outcomes
- atrial fibrillation
- squamous cell
- coronary artery disease
- acute coronary syndrome
- lymph node metastasis